Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending September 30, 2018; Announces Consolidated Earnings Results for the Nine Months Ended June 30, 2018; Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2018
Noevir Holdings Co., Ltd. provided dividend guidance for the year ending September 30, 2018. For the year, the company expects dividend of JPY 150 per share.
The company announced consolidated earnings results for the nine months ended June 30, 2018. For the nine months, the company reported net sales of JPY 43,677 million compared to JPY 41,145 million a year ago. Operating income was JPY 9,176 million compared to JPY 8,394 million a year ago. Ordinary income was JPY 9,282 million compared to JPY 8,607 million a year ago. Income before income taxes was JPY 9,294 million compared to JPY 8,616 million a year ago. Net income attributable to owners of the parent was JPY 4,383 million or JPY 127.55 per share compared to JPY 4,368 million or JPY 123.24 per share a year ago. Net cash provided by operating activities was JPY 3,175 million compared to JPY 6,732 million a year ago. Purchase of property, plant and equipment was JPY 1,009 million compared to JPY 1,315 million a year ago. Purchase of intangible assets was JPY 3 million compared to JPY 42 million a year ago.
The company provided consolidated earnings guidance for the fiscal year ending September 30, 2018. For the year, the company expects net sales of JPY 56,000 million, operating income of JPY 10,700 million, ordinary income of JPY 10,900 million and net income attributable to owners of the parent of JPY 7,300 million or JPY 212.75 per share.
Noevir Holdings Co., Ltd. is a Japan-based company engaged in the manufacture and sale of cosmetics, toiletries, pharmaceuticals and foods, as well as the purchase and sale of cosmetic products. The Company operates in three business segments. The Cosmetics segment is engaged in the manufacture and sale of cosmetics and toiletries, as well as the purchase and sale of cosmetic products. The Pharmaceuticals and Foods segment is engaged in the manufacture and sale of general drugs and foods. The Others segment is engaged in the purchase and sale of apparels, body fashion, aircrafts and vessels, as well as air transportation business.
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
-
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
-
Quality
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending September 30, 2018; Announces Consolidated Earnings Results for the Nine Months Ended June 30, 2018; Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2018
